Amundi’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,938,507
| Closed | -$332M | – | 2005 |
|
|
2025
Q1 | $332M | Buy |
4,938,507
+1,627,051
| +49% | +$109M | 0.12% | 175 |
|
|
2024
Q4 | $284M | Buy |
3,311,456
+692,567
| +26% | +$59.3M | 0.1% | 200 |
|
|
2024
Q3 | $307M | Buy |
2,618,889
+280,325
| +12% | +$32.9M | 0.11% | 182 |
|
|
2024
Q2 | $325M | Buy |
2,338,564
+175,951
| +8% | +$24.4M | 0.12% | 163 |
|
|
2024
Q1 | $266M | Buy |
2,162,613
+671,375
| +45% | +$82.4M | 0.11% | 188 |
|
|
2023
Q4 | $159M | Buy |
1,491,238
+1,359,388
| +1,031% | +$145M | 0.07% | 289 |
|
|
2023
Q3 | $13.5M | Sell |
131,850
-48,878
| -27% | -$4.99M | 0.01% | 779 |
|
|
2023
Q2 | $14.4M | Sell |
180,728
-141,680
| -44% | -$11.3M | 0.01% | 768 |
|
|
2023
Q1 | $25.5M | Sell |
322,408
-311,190
| -49% | -$24.6M | 0.01% | 664 |
|
|
2022
Q4 | $42M | Sell |
633,598
-5,242
| -0.8% | -$347K | 0.02% | 539 |
|
|
2022
Q3 | $33.9M | Sell |
638,840
-56,132
| -8% | -$2.98M | 0.02% | 584 |
|
|
2022
Q2 | $38M | Sell |
694,972
-122,538
| -15% | -$6.71M | 0.03% | 499 |
|
|
2022
Q1 | $49.8M | Buy |
817,510
+2,668
| +0.3% | +$162K | 0.03% | 467 |
|
|
2021
Q4 | $40.6M | Buy |
814,842
+9,202
| +1% | +$458K | 0.03% | 521 |
|
|
2021
Q3 | $38.7M | Sell |
805,640
-273,052
| -25% | -$13.1M | 0.03% | 515 |
|
|
2021
Q2 | $45.2M | Buy |
+1,078,692
| New | +$45.2M | 0.03% | 465 |
|